These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1680650)

  • 1. Stereoselective metabolism of carvedilol in the rat. Use of enantiomerically radiolabeled pseudoracemates.
    Fujimaki M; Shintani S; Hakusui H
    Drug Metab Dispos; 1991; 19(4):749-53. PubMed ID: 1680650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
    Fujimaki M
    Drug Metab Dispos; 1994; 22(5):700-8. PubMed ID: 7835220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two major biliary metabolites of carvedilol in rats.
    Fujimaki M; Hakusui H
    Xenobiotica; 1990 Oct; 20(10):1025-34. PubMed ID: 2082592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective disposition and tissue distribution of carvedilol enantiomers in rats.
    Fujimaki M
    Chirality; 1992; 4(3):148-54. PubMed ID: 1586585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective glucuronidation of carvedilol in human liver and intestinal microsomes.
    Hanioka N; Tanaka S; Moriguchi Y; Narimatsu S
    Pharmacology; 2012; 90(3-4):117-24. PubMed ID: 22814440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound.
    Neugebauer G; Akpan W; Kaufmann B; Reiff K
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S108-11. PubMed ID: 1974498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective metabolism and pharmacokinetics of Casodex in the male rat.
    McKillop D; Simons PJ; Cockshott ID; Hill SJ; Harding JR; Cooper KJ; Jones DC
    Xenobiotica; 1995 Jun; 25(6):623-33. PubMed ID: 7483662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective disposition of carprofen, flunoxaprofen, and naproxen in rats.
    Iwakawa S; Spahn H; Benet LZ; Lin ET
    Drug Metab Dispos; 1991; 19(5):853-7. PubMed ID: 1686227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination and Comparison of the Solubility, Oil-Water Partition Coefficient, Intestinal Absorption, and Biliary Excretion of Carvedilol Enantiomers.
    Zhang Q; Wang X; Xue H; Huang B; Lin Z; Cai Z
    AAPS PharmSciTech; 2021 Jan; 22(1):43. PubMed ID: 33426619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual inhibition between carvedilol enantiomers during racemate glucuronidation mediated by human liver and intestinal microsomes.
    Takekuma Y; Yagisawa K; Sugawara M
    Biol Pharm Bull; 2012; 35(2):151-63. PubMed ID: 22293344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the (+)-, (+/-)-, and (-)-enantiomers of alpha-methylfluorene-2-acetic acid (cicloprofen) in rats.
    Dean AV; Lan SJ; Kripalani KJ; Difazio LT; Schreiber EC
    Xenobiotica; 1977 Sep; 7(9):549-60. PubMed ID: 602253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry.
    Poggi JC; Da Silva FG; Coelho EB; Marques MP; Bertucci C; Lanchote VL
    Chirality; 2012 Mar; 24(3):209-14. PubMed ID: 22271587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction.
    Neugebauer G; Gabor M; Reiff K
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S142-6. PubMed ID: 1378143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat.
    Eeckhoudt SL; Evrard PA; Verbeeck RK
    Drug Metab Dispos; 1997 Apr; 25(4):428-30. PubMed ID: 9107541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay and disposition of carvedilol enantiomers in humans and monkeys: evidence of stereoselective presystemic metabolism.
    Fujimaki M; Murakoshi Y; Hakusui H
    J Pharm Sci; 1990 Jul; 79(7):568-72. PubMed ID: 1975840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective disposition of hydratropic acid in rat.
    Yamaguchi T; Nakamura Y
    Drug Metab Dispos; 1985; 13(5):614-9. PubMed ID: 2865113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
    Lankford SM; Maskasame C; Bai SA
    Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.